Why Innospec Stock Is Falling During Tuesday's After-Hours Session

Innospec Inc. IOSP shares are trading lower by 2.37% to $109.97 during Tuesday's after-hours session. The company reported mixed fourth-quarter financial results.

What Happened?

Innospec reported quarterly earnings of $1.20 per share, which missed the analyst consensus estimate of $1.39. The company also reported quarterly sales of $510.70 million that beat the analyst consensus estimate of $485.73 million by 5%. This sales figure is a 23.6% increase over sales of $413.2 million in the same period last year.

See Also: Why Donnelley Financial Solutions (DFIN) Shares Are Getting Hammered

Innospec says the company generated cash from operating activities of $78.4 million before capital expenditures of $15.1 million in the quarter. Innospec also closed the quarter with net cash of $147.1 million, up from net cash of $100.5 million at the end of the third quarter.

In the fourth quarter, the company says it paid its semi-annual dividend of 65 cents per common share and repurchased 8,514 of its common shares at a cost of $700,000.

What Else?

Commenting on the fourth quarter results, Patrick S. Williams, president and CEO, said: "This was another very strong quarter for Innospec. In the quarter and the full-year we delivered double-digit sales and operating income growth with expanded margins. We again benefited from our balanced end-market exposure as some negative impact of year-end customer destocking in Performance Chemicals was offset by continued sequential growth in Oilfield Services and steady results in Fuel Specialties.

According to data from Benzinga Pro, IOSP has a 52-week high of $115.66 and a 52-week low of $83.13.

Photo via Shutterstock. 

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsDividendsBuybacksTop StoriesAfter-Hours Centerwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...